Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma
Benjamin E Stubbe*, Poul H Madsen, Anders C Larsen, Henrik B Krarup, Inge S Pedersen, Carsten P Hansen, Julia S Johansen, Stine D Henriksen, Ole Thorlacius-Ussing
Dive into the research topics of 'Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma'. Together they form a unique fingerprint.